BACKGROUND: To evaluate the ability of ultrahigh-field magnetic resonance imaging (MRI) to accurately depict the composition of the human arterial vessel wall ex vivo and to detect early atherosclerotic lesion formation in comparison to histology. METHODS: Eight iliac artery specimens with low-grade atherosclerotic lesions obtained from human organ donors were studied. Three-dimensional, high-resolution MRI (spatial resolution: 79 x 79 x 109 microm) was performed using T1-, T2- and proton density (PD)-weightings (7.0 Tesla MR system, Bruker Pharmascan). A total of 36 MR slices and corresponding histological sections were matched for comparative evaluation of area measurements of lumen, media and adventitia and--if present--plaque size. Statistical correlation between histology and MR measurements was tested and a ROC-analysis was performed to determine the plaque size being predictive of correctly identifying atherosclerotic lesions with MRI. RESULTS: The areas of vessel lumen and media as measured on T1-, T2- and PD-weighted MR images showed a strong correlation with the corresponding histological measurements (r = 0.84 to r = 0.89; P < 0.01), however, a systematic overestimation of 34-41% was found. For the area of adventitia, only a moderate, though significant, correlation (r = 0.55 to r = 0.62; P < 0.01) could be demonstrated with a similar overestimation by MRI (38-43%). With T1-weighted MRI, sensitivity and specificity for the detection of plaques > 4.0 mm(2) were 79% and 91%, respectively. With T2- and PD-weighted MRI, however, sensitivity and specificity for the detection of plaques > 0.4 mm2 were 93% and 89%. CONCLUSIONS: In an experimental ex vivo setting, ultrahigh-field MRI of the human arterial vessel wall resulted in an accurate visualization of vessel wall composition when compared to histology and, thus, allowed for a quantitative assessment. T2- and PD-weighted MRI proved capable of reliably detecting submillimeter atherosclerotic lesions.
BACKGROUND: To evaluate the ability of ultrahigh-field magnetic resonance imaging (MRI) to accurately depict the composition of the human arterial vessel wall ex vivo and to detect early atherosclerotic lesion formation in comparison to histology. METHODS: Eight iliac artery specimens with low-grade atherosclerotic lesions obtained from human organ donors were studied. Three-dimensional, high-resolution MRI (spatial resolution: 79 x 79 x 109 microm) was performed using T1-, T2- and proton density (PD)-weightings (7.0 Tesla MR system, Bruker Pharmascan). A total of 36 MR slices and corresponding histological sections were matched for comparative evaluation of area measurements of lumen, media and adventitia and--if present--plaque size. Statistical correlation between histology and MR measurements was tested and a ROC-analysis was performed to determine the plaque size being predictive of correctly identifying atherosclerotic lesions with MRI. RESULTS: The areas of vessel lumen and media as measured on T1-, T2- and PD-weighted MR images showed a strong correlation with the corresponding histological measurements (r = 0.84 to r = 0.89; P < 0.01), however, a systematic overestimation of 34-41% was found. For the area of adventitia, only a moderate, though significant, correlation (r = 0.55 to r = 0.62; P < 0.01) could be demonstrated with a similar overestimation by MRI (38-43%). With T1-weighted MRI, sensitivity and specificity for the detection of plaques > 4.0 mm(2) were 79% and 91%, respectively. With T2- and PD-weighted MRI, however, sensitivity and specificity for the detection of plaques > 0.4 mm2 were 93% and 89%. CONCLUSIONS: In an experimental ex vivo setting, ultrahigh-field MRI of the human arterial vessel wall resulted in an accurate visualization of vessel wall composition when compared to histology and, thus, allowed for a quantitative assessment. T2- and PD-weighted MRI proved capable of reliably detecting submillimeter atherosclerotic lesions.
Authors: W Yong Kim; Matthias Stuber; Peter Börnert; Kraig V Kissinger; Warren J Manning; René M Botnar Journal: Circulation Date: 2002-07-16 Impact factor: 29.690
Authors: D Bruemmer; U Riggers; J Holzmeister; M Grill; F Lippek; U Settmacher; V Regitz-Zagrosek; E Fleck; K Graf Journal: Am J Cardiol Date: 2001-01-01 Impact factor: 2.778
Authors: G Helft; S G Worthley; V Fuster; A G Zaman; C Schechter; J I Osende; O J Rodriguez; Z A Fayad; J T Fallon; J J Badimon Journal: J Am Coll Cardiol Date: 2001-03-15 Impact factor: 24.094
Authors: Fuxing Yang; Gerhard Holzapfel; Christian Schulze-Bauer; Rudolf Stollberger; Daniel Thedens; Lizann Bolinger; Alan Stolpen; Milan Sonka Journal: Int J Cardiovasc Imaging Date: 2003-10 Impact factor: 2.357
Authors: A G van der Kolk; J J M Zwanenburg; N P Denswil; A Vink; W G M Spliet; M J A P Daemen; F Visser; D W J Klomp; P R Luijten; J Hendrikse Journal: AJNR Am J Neuroradiol Date: 2014-12-04 Impact factor: 3.825
Authors: Dimitris Mitsouras; Christopher D Owens; Michael S Conte; Hale Ersoy; Mark A Creager; Frank J Rybicki; Robert V Mulkern Journal: Magn Reson Med Date: 2009-09 Impact factor: 4.668
Authors: John T Melchior; John D Olson; Kathryn L Kelley; Martha D Wilson; Janet K Sawyer; Kerry M Link; Lawrence L Rudel Journal: Arterioscler Thromb Vasc Biol Date: 2015-07-30 Impact factor: 8.311
Authors: Frank John Rybicki; Dimitrios Mitsouras; Christopher D Owens; Amanda G Whitmore; Hale Ersoy; Robert V Mulkern; Mark A Creager; Michael S Conte Journal: Int J Cardiovasc Imaging Date: 2007-12-14 Impact factor: 2.357